Guru Ownership Trend
Guru Analysis for Catalyst Pharmaceuticals, Inc. (CPRX)
Catalyst Pharmaceuticals, Inc. (CPRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $192.83 M.
Top institutional holders include Renaissance Technologies (RenTech) and Chuck Royce.
Institutional sentiment is currently Bearish. This is evidenced by a $56.79 M net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Terry Smith reduced exposure by 74.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Catalyst Pharmaceuticals, Inc. (CPRX)
Major holders include Renaissance Technologies (RenTech) ($58.12 M), Chuck Royce ($51.75 M), Terry Smith ($20.92 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 6.18 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $56.79 M, with 3 managers increasing positions and 6 managers reducing holdings.
During the most recent reporting period, 6 managers trimmed their positions, while 0 fully exited CPRX. The total reported sell value was $72.28 M.
Yes, 2 managers opened new positions in CPRX, and 1 increased their existing holdings. The total reported buy value was $15.48 M.
